Brief: ABVC BioPharma Reports Third Quarter 2022 Financial, Operational Results
14/11/2022 23:22
Nov 14 (Reuters) - ABVC BioPharma Inc ABVC.O :
* ABVC BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL AND
OPERATIONAL RESULTS
* ABVC BIOPHARMA INC - QTRLY LOSS PER SHARE OF $0.11
Source text for Eikon: ID:nGNX8t9fQZ
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner